Institute 4 (ticket)
The Developmental Neuropsychiatry of Intellectual Developmental Disability: Advances in Classification, Diagnosis, and Treatment

This Institute details the new DSM-5 definition of Intellectual Disability/Intellectual Developmental Disorder (ID/IDD), emphasizing the importance of psychiatry in the assessment, diagnosis, and treatment of children and adolescents with ID/IDD who have co-occurring psychiatric disorders, and discussing recent advances in treatment targeted to neurobiological mechanisms, behavioral therapies (including severe behaviors), family-focused therapies to alleviate distress, and psychopharmacological interventions. Attendees gain understanding of the essential role played by child and adolescent psychiatrists in light of the DSM-5 now identifying gullibility and lack of risk awareness as characteristic features in determining the severity of ID/IDD and requiring a face-to-face clinical psychiatric assessment. Legal, forensic, and ethical issues are also part of the discussion. Child and adolescent psychiatrists receive limited training in this area and benefit from the knowledge of experts in the field.
Wednesday, October 28, 2015: 7:30 AM-4:00 PM
Chair:
7:30 AM  
Introduction
7:45 AM  
4.1
DSM-5 Classification of Intellectual Disability (Intellectual Developmental Disorder): New Emphasis on Adaptive Reasoning
James C. Harris, MD The Johns Hopkins University School of Medicine, Baltimore, MD
8:30 AM  
4.2
Targeted Treatment for Neurodevelopmental Disorders: Reversing Underlying Neurobiological Deficits in Fragile X Syndrome
Dejan B. Budimirovic, MD Clinical Trials Center, Kennedy Krieger Institute, The Johns Hopkins Medical Institutions, Baltimore, MD
9:15 AM  
Break
9:30 AM  
4.3
The Co-Occurrence of Other Mental Disorders in Children and Adolescents With Intellectual Disability/Intellectual Developmental Disorder
Kerim M. Munir, MD, DSc Bostonís Childrenís Hospital and Harvard Medical School, Boston, MA
10:15 AM  
4.4
Pharmacotherapy for Co-Occurring Psychiatric Conditions in Intellectual Disability and Autism Spectrum Disorder
Robert L. Findling, MD, MBA The Johns Hopkins University School of Medicine, Baltimore, MD
11:00 AM  
Break
11:15 AM  
Panel Discussion
11:45 AM  
Lunch (on your own)
1:00 PM  
4.5
Behavior Analytic Approaches to Problem Behavior in Intellectual Disability (Intellectual Developmental Disorder)
Louis Hagopian, PhD Kennedy Krieger Institute, Baltimore, MD
1:45 PM  
4.6
Treatment Approaches for Families of Children With Neurodevelopmental Disabilities
Elisabeth Dykens, PhD Vanderbilt Kennedy Center and Vanderbilt University Medical Center, Nashville, TN
2:30 PM  
Break
2:45 PM  
4.7
Legal, Forensic, and Ethical Issues in Intellectual and Developmental Disabilities
Ludwik S. Szymanski, MD Bostonís Childrenís Hospital and Harvard Medical School, Chestnut Hill, MA
3:30 PM  
Panel Discussion With Question and Answer

Sponsored by the AACAP Autism and Intellectual Disability Committee

See more of: Institute
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.